Focus Taiwan
Date: 2016/03/25
By: Liu Shih-yi, Wang Cheng-chung, Wen Kuei-hsiang and Lilian Wu

Taipei, March 25 (CNA) Prosecutors looking into potential insider trading of OBI Pharma shares said Friday that the daughter of Academia Sinica President Wong Chi-huey (翁啟惠) sold some of her stocks in the company three months before it announced a failed trial of its new cancer drug, which sent its stock price plunging.

The Shihlin Prosecutors Office said, however, that the exact number of shares sold by Wong Yu-shioh (翁郁琇) and the flow of the funds still have to be checked.

Prosecutors have screened data supplied by the Financial Supervisory Commission on the 50 biggest traders of OBI Pharma shares prior to when the failed test was announced on Feb. 21, and Wong’s daughter was not among that group, the Shihlin office said.

The office said it would expand the list to check the top 100 traders of OBI Pharma shares during the period, without specifying how long of a period before the announcement is covered by the data.    [FULL  STORY]